Consensus Cloud Solutions (CCSI) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
10 Feb, 2026Executive summary
Achieved record Q4 and full year 2025 results, with consolidated Q4 revenue of $87.1M, driven by 7.3% corporate revenue growth and strong operational performance.
Corporate channel now represents 64% of total revenue, up from 60% in 2024, and is projected to reach 68% in 2026.
Free cash flow hit a record $106M for 2025, up 20% from 2024, supporting continued investment and share repurchases.
Debt reduced by $36M in 2025, with $243M in debt retired since the spin and refinancing of 6% Notes due 2026.
SoHo channel revenue declined 11.1% in Q4 and 10% for the year, reflecting the strategic pivot to a cash engine.
Financial highlights
Q4 2025 consolidated revenue was $87.1M, up 0.1% year-over-year, marking the third consecutive quarter of growth.
Adjusted EBITDA for Q4 was $45.2M (51.9% margin); full year Adjusted EBITDA was $186.9M–$187M (53.4% margin).
Adjusted net income for Q4 was $27.3M, up 12.7% year-over-year; full year Adjusted net income was $109.4M, up 3.6%.
Adjusted EPS for Q4 was $1.41 (up 13.7%); full year Adjusted EPS was $5.62 (up 3.1%).
Ended 2025 with ~$75M in cash and $562M in debt; repurchased 1M shares for $23M in 2025, with $57M cumulative repurchases.
Outlook and guidance
2026 revenue guidance: $350M–$364M (midpoint $357M), ~2% growth at midpoint.
2026 Adjusted EBITDA guidance: $182M–$193M (midpoint $187.5M); Adjusted EPS: $5.55–$5.95 (midpoint $5.75).
Q1 2026 revenue guidance: $85.4M–$89.4M; Adjusted EBITDA: $43.8M–$46.8M; Adjusted EPS: $1.36–$1.46.
Corporate revenue expected to grow 7.2%–11.2% in 2026; SoHo revenue expected to decline 8.3%–12.3%.
Free cash flow expected to approximate 2025 record levels; more aggressive share repurchases planned.
Latest events from Consensus Cloud Solutions
- Healthcare solutions and recurring revenue drive growth as FY2024 guidance is reaffirmed.CCSI
Goldman Sachs 45th Annual Global Healthcare Conference3 Feb 2026 - Net income and margins rose in Q2 2024 despite lower revenue, with improved guidance for the year.CCSI
Q2 20241 Feb 2026 - Healthcare interoperability, AI, and capital returns drive growth and margin improvement.CCSI
Jefferies Global Healthcare Conference31 Jan 2026 - Q3 revenue fell 3.1% but margin gains and debt reduction supported strong corporate growth.CCSI
Q3 202415 Jan 2026 - Record free cash flow, margin strength, and debt reduction highlight 2024 performance.CCSI
Q4 202423 Dec 2025 - Proxy covers director elections, auditor ratification, pay, ESG, and strong governance.CCSI
Proxy Filing2 Dec 2025 - Virtual meeting to vote on directors, auditor, and executive pay, all board-recommended.CCSI
Proxy Filing2 Dec 2025 - Q1 2025 revenue down 1.1%, Corporate growth offsets SoHo decline; guidance reaffirmed.CCSI
Q1 202525 Nov 2025 - Corporate revenue up 6.9% year-over-year, driving first total revenue growth in eight quarters.CCSI
Q2 202523 Nov 2025